NewAmsterdam Pharma (NAMS) Amortization of Deferred Charges (2025 - 2026)
NewAmsterdam Pharma's (NAMS) quarterly Amortization of Deferred Charges came in at $10000.0 in Q1 2026, up 101.95% year-on-year from $4951.7 in Q1 2025, and up 141.67% quarter-over-quarter from -$24000.0 in Q4 2025.
NewAmsterdam Pharma (NAMS) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
NewAmsterdam Pharma has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $10000.0 for Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $10000.0, up 101.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$882000.0 (changed N/A YoY), and the FY2025 annual result was -$1.4 million, down 518.94% from the prior year.
- Amortization of Deferred Charges came in at $10000.0 for Q1 2026 at NewAmsterdam Pharma, up from -$24000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $10000.0 in Q1 2026 to a low of -$513000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | NewAmsterdam Pharma | 3.63 Bn | 3.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -396,000.00 |
| Sep 30, 2025 | -396,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Mar 31, 2025 | -513,000.00 |
| Mar 31, 2025 | -513,000.00 |